Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Int J Proteomics. 2011;2011:343582. doi: 10.1155/2011/343582. Epub 2011 Aug 11.

Protein biomarkers for the early detection of breast cancer.

Author information

  • 1Department of Surgery, University of Michigan Medical School, Ann Arbor, MI 48109-5656, USA.

Abstract

Advances in breast cancer control will be greatly aided by early detection so as to diagnose and treat breast cancer in its preinvasive state prior to metastasis. For breast cancer, the second leading cause of cancer-related death among women in the United States, early detection does allow for increased treatment options, including surgical resection, with a corresponding better patient response. Unfortunately, however, many patients' tumors are diagnosed following metastasis, thus making it more difficult to successfully treat the malignancy. There are, at present, no existing validated plasma/serum biomarkers for breast cancer. Only a few biomarkers (such as HER-2/neu, estrogen receptor, and progesterone receptor) have utility for diagnosis and prognosis. Thus, there is a great need for new biomarkers for breast cancer. This paper will focus on the identification of new serum protein biomarkers with utility for the early detection of breast cancer.

PMID:
22084684
[PubMed]
PMCID:
PMC3195294
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk